TESSA THERAPEUTICS
2017
We were an early and key investor of Tessa Therapeutics, a Singapore-based biotechnology company developing novel cell therapies for cancer.
PROMETHEUS BIOSCIENCES
2018
We were an early and key investor in Prometheus Biosciences, a biotechnology company that utilizes precision medicine to target immune-medicated diseases.
Asia Opportunity Segregated Portfolios
2019
We manage several portfolios that focus on public debt and equity investments driven by fundamental analysis. The portfolios emphasize APAC- and US-based investments in multiple sectors including technology, healthcare, and commodities.
Stanmore Resources
2022
We provided a US $120 million loan facility to Stanmore Resources as part of their US $1.2 billion deal to purchase an 80% interest in BHP Mitsui Coal (BMC). The deal positions Stanmore as a global leader in metallurgical coal exportation.
Stanmore Resources
2020
In conjunction with Golden Energy and Resources (GEAR), we completed an on-market takeover of Stanmore Resources, an Australian coal company. At the on-market purchase price of AUD 1 per share, we acquired a 75.33% stake in the company, which represented a value of ~A$203 million (~US $155 million) in 2020.
Widgie Nickel
2023
We participated in the company’s AU $12 million placement in 2023, becoming a substantial (9.9%) shareholder. The deal enables continued exploration and development of the company’s Mt Edwards Project.
Moladin
2022
We are a key investor of Moladin, an Indonesia-based omnichannel used car marketplace.
Fundtastic
2019
We are a key investor of Fundtastic, an Indonesia-based financial technology company that operates a personal finance and investing platform.
Infrastructure
2023
We participated in a deal involving Magnetic Rail Group’s acquisition of railway assets from One Rail Australia,owned by Aurizon Holdings, worth AU ~$425M.